Skip to main content

DermTech Falls After Cigna Tells Bloomberg No Change To Genetic Testing Coverage

DermTech shares rallied yesterday after Craig-Hallum said that Cigna has become the first insurer to cover the company's Pigmented Lesion Assay genetic test.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.